The widespread application of red cell survival techniques has revealed the importance of excessive red cell destruction in the pathologic physiology of many of the anemias. An increasing array of in vitro methods for detecting red cell or serum abnormalities has provided insight into the in vivo mechanisms underlying some of these processes. In certain disease states the presence of visible or physically measurable alterations of the red cells has permitted detection of the sites and to some extent of the mechanisms of sequestration of these cells. Such valuable observations have been made upon pathologic material from patients with congenital hemolytic anemia (1) (2) (3) (4) (5) and sickle cell anemia (1, (5) (6) (7) . The need has continued to exist, however, for a clinical method by which to determine the sites of red cell destruction, both for an understanding of the relationship between red cell abnormalities and the body's red cell clearing mechanisms, and for pragmatic aid in the often difficult decisions concerning splenectomy.
The potential usefulness of Na2Cr5104-labelled red cells in the clinical determination of the sites of red cell destruction was suggested to us by observations on postmortem tissues taken from a patient with the hemolytic anemia of liver disease, who succumbed during observation of the survival of Cr5'-labelled autogenous red cells.2 The Crp5 activity of the patient's splenic tissue was greater than that of other tissues even when correction was made for the Cr5l activity of the residual red cells. Moreover, the radioactivity of the packed red cells removed from the spleen exceeded that of a comparable sample of packed red cells from the peripheral blood. In order to investigate the possibility that Cr51-labelled red cell deposition could be determined by measuring body surface radioactivity, several questions required exploration: 1) Are the emanations of Cr 5 suitable for external body scanning at safe dosage levels? 2) Does the site of tissue deposition of Cr65 following the intravenous injection of Cr51-labelled red cells necessarily indicate the site of deposition of whole red cells? 3) Is the turnover of Cr5I deposited in tissues sufficiently slow to provide a detectable accumulation? 4) Finally, do the results obtained confirm the information already established in certain specific instances, for example, in congenital hemolytic anemia and in sickle cell anemia? In order to investigate these questions, observations were first made on the distribution of Cr5' in normal subjects. The fate of Cr51-labelled autogenous red cells was then observed in patients with known intracorpuscular defects and, lastly, in patients with certain diseases generally characterized by excessive red cell destruction and a preliminary report (10) was made.
METHODS
Cr' labelling technique. All red cell labelling was performed under sterile conditions with Na,CrMO43 diluted with normal saline to a concentration of about 30 micrograms of chromium per cubic centimeter. Between 100 and 150 microcuries of Cr5' in this form were added with immediate mixing to 50 cc. of whole blood in a siliconized flask containing 12 cc. of acid-citrate-dextrose solution. The flask was then gently agitated continuously for 45 3 "Rachromate," Abbott Laboratories, North Chicago, Illinois.
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FIGURE 1
The gradual, almost linear, disappearance of Cr'-labelled normal autogenous red cells from the blood stream shown in the upper portion of the figure is reflected by ,a gradual accumulation of Cr' in the tissues. Little difference exists in the levels of relative radioactivity over liver and spleen, as depicted in the lower portion of the figure.
minutes. Unbound or reduced chromium was removed by washing the red cells once in sterile normal saline, after which the red cells were suspended in 2 volumes of normal saline preparatory to injection. Over 99 per cent of the Cr' injected was in the red cells.
Solutions of Cr'-labelled hemoglobin were prepared by similarly labelling red cells which were thereafter washed 5 times in normal saline and then hemolyzed with 4 volumes of distilled water. 4 After adjusting the sodium chloride concentration of the suspending fluid to 0.85 gm. per cent, the red cell "ghosts" were centrifuged down and the supernatant solution was Seitz-filtered prior to injection. 4 It is equally feasible to label the hemnoglobin in solution after hemolysis; this may be done either with Na2CrMO4 or Cr'Cl..
A solution of a reduction product of Na2CrkO,, Cr'G13,5 was diluted with normal saline to a suitable volume; this was injected directly intravenously in one instance and after preliminary incubation with serum in another.
Specimen collection and Crt determination. Following injection of Crc-containing preparations, venous blood specimens were collected at appropriate intervals in bottles containing dry "balanced" oxalate. Their radioactivity was determined after hemolysis by freezing and thawing. Specimens for the measurement of plasma radioactivity were drawn into saline-wetted syringes and the citrated plasma removed after centrifugation of the specimens within one hour of their procurement. The plasma samples were then frozen and thawed along with 5 Radioactive chromic chloride, Abbott Laboratories, North Chicago, Illinois. the whole blood samples. Plasma Cru activity was expressed as a percentage of the whole blood activity by correction for the plasma volume of a sample of whole blood. When possible, all urine was collected as individual specimens for about 18 hours after the Cr' injection, and thereafter 24-hour urine collections were made. In several subjects serial 2-or 4-day total stool collections were made. The stool specimens were digested with 10 per cent sodium hydroxide and mixed in a blender before sampling.
The radioactivity of all types of materials was determined with a well-type scintillation counter. The "zerotime" peripheral blood radioactivity was estimated by extrapolation of a line drawn visually through points on semilogarithmic graph paper on which the concentration of whole blood Cr' was plotted against time. From this value the initial blood volume was calculated by the dilution principle and the CrM concentration of the circulating blood was thereafter expressed as a percentage of the zero time value. The Cr'1 content of the circulating blood was calculated as the product of the blood Cr' concentration and the blood volume, by making the assumption that the latter was unchanged during the period of study.
Red cell survival at any time was then taken as the percentage of the injected Cr's which remained in the circulating blood. For graphic presentation data so obtained were plotted against time on rectilinear graph paper without correction for Cr' "elution" from the red cells. The blood Cr'1 activity was followed in most subjects until its disappearance. However, for easier com- FIGUE 2 Following intravenous injection of Crh-labelled hemoglobin solution, radioactivity disappeared from the blood at a continuously slowing rate with a half-disappearance time of 3 hours, whereas by chemical determination plasma hemoglobin was removed from the circulation "exponentially" with a half-time of from 1% to 2 hours. With the removal of Cr' from the peripheral blood, there was a rapid, prominent rise in radioactivit-y over the liver and to a lesser extent over the spleen. 
FIGURE 3
The upper portion of this figure indicates the great rapidity with which injected cationic trivalent Crm in saline is cleared from the circulation. Most of this chromium appeared in the urine, with only a slight accumulation by the liver and spleen. Preliminary incubation of Cr'Cl, and serum before injection enhanced the relative Cr's uptake by the liver.
parison of data, a time axis of only 30 days was employed in the presentation of the studies of individual patients shown below in Figures 1 to 13 . The urinary excretion of Cr' was expressed as the cumulative percentage of the injected dose of Cr'. Since in no instance was Cr'1 excreted in the patients' stools, the chromium not accounted for in blood or urine was designated as "tissue Cr"' in the figures and in Table I .
Body surface counting. Body surface counting was performed with a directional scintillation counter having a conical collimator 4 inches in depth and 3 inches in internal diameter at the open end. Twenty minutes after the injection of materials labelled with CrM, each patient was scanned. In no instance among the patients reported here were high levels of activity found other than over the heart, liver, or spleen. In each patient, therefore, surface projections of these organs were determined by physical examination and their approximate centers were marked with a skin pencil. In some patients radioactivity levels were also followed over the thoracic, lumbar and sacral areas. In performing each count the scintillation counter was plumb-centered over the appropriate mark with the patient in a standardized position, permitting the body surface overlying the organ to approximate parallelism with the collimator surface. The counter was then lowered to direct apposition with the body surface and two or more measurements were made with an automatic scaler.
In measuring the body surface radioactivity, it was recognized that a variable but important degree of radioactivity over each organ derived from the activity of the perfusing blood, as well as from stray radiation from one 845 organ to another. Since the geometric complexities involved prevented calculation of the absolute levels of organ radioactivity, a relative expression was employed.
The precordial Cr' activity grossly paralleled the activity of whole blood specimens and presumably emerged largely from the perfusing blood.6 Body surface counts were therefore expressed as the ratio of the radioactivity over a certain organ to that at the same time over the heart.
This ratio represents a function of the quantity of Cr' accumulated in the organ concerned, whether in red cells Is It is apparent, however, that precordial radioactivity reflects blood radioactivity most accurately when there is the least stray irradiation from neighboring organs such as the spleen.
or not, and-may be regarded-as a -crude measure of a gradient between the organ and the circulating blood.
Miscellaneous techniques. Plasma and urine hemoglobin levels were measured by a photoelectric adaptation (11) of the benzidine method of Bing and Baker. The mean normal value for plasma hemoglobin concentration in this laboratory is 2.6 + 1.2 mg. (2 S.D.) per cent.
Clinical material. The "normal" subjects studied were elderly males hospitalized for minor illnesses and/or for sociologic reasons. Three of these were given autogenous Cr'-labelled red cells. The 11 anemic patients displayed findings characteristic of their diseases. A brief summary of the vital statistics and of some of the hematologic data from these 14 subjects and patients is presented in Table I .
FIGURE 4A
The increased rate of Cr'-labelled red cell destruction in a patient, Case factor for the "elution" of Crl1 from normal red cells was again employed, although recognizing that this rate may actually differ for diseased red cells. In one anemic patient, Case 9, despite stable peripheral blood levels during the observation period, the Cr51-labelled red cell survival data corrected for elution produced a straight line on neither rectilinear nor semilogarithmic graph paper. This survival curve presumably reflected a mixture of accelerated senescence and of random destruction. The rate of red cell destruction in Case 9 was estimated by a simple method for determining the mean red cell life span based on the concept of total red cell days (13) .
The rates of hemoglobin production shown in Table I were determined in those 10 anemic subjects manifesting random red cell destruction as the product of the calculated rate of red cell destruction and the mean total circulating hemoglobin level during the period of observation. In the normal subjects and in one anemic subject, Case 9, with a mixed hemolytic process hemoglobin production was calculated on the basis of the estimated mean red cell lifespan.
Fate of Cr"l derived from labelled red cells, hemoglobin, and chromic chloride
Observations on one of the normal subjects who received Cr5l-labelled autogenous red cells are pre-
The CrT-labelled red cells of a patient, Case 3, with moderately severe sickle cell anemia were removed from the circulation in an "exponential" fashion and showed a half-survival time of 11.2 days. There was a moderate increase in radioactivity over the liver but not over the splenic area. The simultaneously observed survival of red cells from Case 3 in a normal compatible recipient was appreciably shorter with a half-survival time of 6.0 days. This was associated with high levels of radioactivity over both spleen and liver. Note also the smaller excretion of Cr'1 in the urine of this subject.
sented in Figure 1 . Figure 1 depicts the slow minimal increase in relative radioactivity occurring almost equally over liver and spleen thereafter. Each of three other normal subjects (not listed in Table I ) was given 1 gm. of Cr51-labelled autogenous hemoglobin injected intravenously over a period of 2 or 3 minutes. This produced no hemoglobinuria or hemosiderinuria and led to zero-time plasma hemoglobin levels which ranged from 30 to 40 mg. per cent. Hemoglobin, as determined colorimetrically, was cleared from the plasma in an exponential fashion with a half-disap-849 pearance time of from 1.5 to 2 -hours. In con--trast, both the whole blood and the plasma Cr5' activity disappeared at a slower rate with a hafdisappearance time of about 3 hours and a continually slowing rate of disappearance thereafter ( Figure 2 ). Although this in vivo "separation" of chromium from hemoglobin began shortly after injection, Cr51-labelled hemoglobin incubated at 370 C. in vitro in the presence of serum retained its radioactivity for 24 hours, as determined by electrophoresis and radioautography.7 As depicted 7 In a similar study Crk initially bound to gamma globulin (Cohn fraction II-1, 2) migrated electrophoretically with the albumin and alpha globulin after 24 hours' incubation of the labelled gamma globulin with normal plasma. in Figure 2 , after 24 hours in vivo 60 per cent, and by 8 days 75 per cent of the Cr5l removed from the blood stream was deposited in the body tissues. The highest level of body radioactivity appeared over the liver and approached a maximum within 6 hours; a parallel but lesser rise in radioactivity appeared over the spleen. Following the injection of 1 gm. of Cr51-labelled hemoglobin into a splenectomized patient the rate of disappearance of Cr5' and of hemoglobin from the plasma was similar, but there was no increase in radioactivity over the "spleen" area. The maximal hepatic activity in this patient, as in normal subjects, approximated 3 times that of the precordium. Twenty-four hours after the injection of Cr51- FIGURE 6 The red cell half-survival time in this patient, Case -o~I E i 1o 15 
DAYS
FIGURE 7A The early rapid phase of red cell destruction depicted in this patient, Case 5, with paroxysmal nocturnal hemoglobinuria and splenomegaly presumably represented destruction of the patient's own red cells with a half-survival estimated at about 7.2 days. The late slow phase was presumed to represent disappearance of the normal previously transfused red cells which were estimated to constitute 30 per cent of those in circulation at the time of labelling with chromium. An increased accumulation of Cr6' by the patient's enlarged spleen was observed. This uptake was about half that of a patient with hereditary spherocytic anemia, Case 1, whose red cell survival was similar ( Figure 4A ). labelled autogenous hemoglobin solution into a dog, the concentrations of radioactive chromium in the liver and spleen of the sacrificed animal were similar and greatly exceeded those of the lungs, lymph nodes and bone marrow. An intermediate concentration of radioactivity was found in the kidney. The major amount of chromium was thus present in the heaviest organ, the liver.
The fate of a reduction product of sodium chromate, trivalent cationic chromium, was investigated in two normal subjects. In the first subject, Cr511CJ was injected in saline intravenously; and in a second subject after preliminary incubation with the recipient's serum at 370 C. for one hour. In both, most of the Cr5' was promptly removed from the blood stream and in large part excreted in the urine. The half-disappearance time of Cr5' from the blood stream was about 15 minutes in each instance. In the first subject, as shown in Figure 3 , a slight progressive hepatic uptake of Cr5' occurred. In the second, a hepatic uptake of two times that of the precordium was observed at the end of 24 hours. In neither case was significant splenic radioactivity noted.
Patients utith intracorpuscular defects Congenital hemolytic anemia. Studies of a patient, Case 1, with moderately severe congenital hemolytic anemia (hereditary spherocytosis) demonstrated an abbreviated exponential red cell survival curve in which half the cells were removed in 8.0 days ( Figure 4A ). Radioactivity over the moderately enlarged spleen was 124 per cent of that of the precordium at zero-time and the relative splenic radioactivity increased steadily in general proportion to the decline in blood activity to reach about 400 per cent of that of the precordium after 25 days. Hepatic Crp5 activity remained low. No hemoglobin or Cr5l appeared in the patient's plasma.
A second patient, Case 2, with hereditary spherocytosis and anemia of tmild intensity, showed similar but less pronounced findings (Figure 4B) . The red cell half-survival in this patient was 11.9 days. At that time the relative splenic radioactivity was over twice that of the precordium. Again, the initial radioactivity over the patient's enlarged spleen exceeded that of the normal subjects and that over the liver remained low.
A similar increase of Cr5' occurred over the spleen of a normal subject of compatible blood group who received labelled red cells from Case 2. The Injection of the red cells of the same patient, Case patient's red cells were destroyed more rapidly in the normal recipient than in the patient himself.
Sickle cell anemia. The fate of the red cells of a patient, Case 3, with sickle cell anemia is depicted in Figure 5A . Half of these red cells were removed from the blood stream in 11.2 days at which time about 70 per cent of the derived Cr5' (35 per cent of that injected) was retained in the body. A moderate gradual increase in hepatic Cr5' uptake accompanied the disappearance of Cr5l from the blood, whereas "splenic" radioactivity was initially abnormally low and increased little thereafter. A second patient with sickle cell anemia, not reported here, showed almost identical findings. Simultaneously with the study depicted in Figure 5A, (Figure 6 ). There was, accompanying red cell destrudtion during the first 15 days after this, a moderate increase in splenic radioactivity the injection of the labelled mixed red cell populabeyond the initially elevated relative radioactivity tion, which presumably represented largely deover the patient's moderately large spleen. struction of autogenous red cells, there was a Paroxysmal nocturnal hemoglobinuria. The moderate increase in radioactivity over the pahalf-survival time of the Cr51-labelled autogenous tient's enlarged spleen. Subsequently a slight dered cells of a patient, Case 5, with paroxysmal-noc-cline in relative radioactivity over both spleen and turnal hemoglobinuria was 7.2 days ( Figure 7A ). liver attended a progressive slowing of the rate of At the time of labelling approximately 30 per cent Cr5l disappearance from the blood presumably asof the circulating red cells were normal previously sociated with the slower destruction of the normal FIGURE 9 In this patient, Case 7, with severe Laennec's cirrhosis and macrocytic anemia associated with; chronic alcoholism the increased rate of disappearance of Cr" from the blood indicated a moderately severe hemolytic process characteristic of this disease. This was associated with a distinct and progressive accumulation of Cr" over the patient's non-palpable spleen. Note also the initial and sustained abnormally low relative radioactivity over the patient's enlarged liver. This was observed in 3 other patients with cirrhosis, and presumably reflects a reduction in hepatic vascularity. ulocyte levels (ranging from 8 to 24 per cent), hyHemoglobin C disease. A patient, Case 6, with peractive erythroid elements in the bone marrow, a slight anemia, normal reticulocyte levels, many and increased urobilinogen excretion frequently target cells, and a hemoglobin mobility on filter observed in this disease (14) . The red cell halfpaper electrophoresis characteristic of hemoglobin survival time was 6.0 days (Figure 9 ). There C disease, demonstrated a moderate reduction in was a moderate progressive increase of radioacthe survival of autogenous red cells labelled with tivity over the spleen. The Cr5' radioactivity over Crl (Figure 8) . Associated with this was a small the liver one-half hour after injection of the lagradual increase in radioactivity over the spleen belled red cells was abnormally low, 43 per cent and somewhat less over the liver, of that over the precordium, and remained low. In 3 other patients with cirrhosis this initial value
Patintswithextacopusclaror ixeddefcts ranged from 40 to 60 per cent whereas in 6 normal subjects it ranged from 60 to 80 per cent of that Liver disease. A patient, Case 7, with advanced over the precordium. Subsequently, Cr51-labelled cirrhosis and macrocytic anemia associated with hemoglobin was injected intravenously into this Ths.ptet ae9 a arysvr,sal nmaascae ihuei 0eutn rmcrncpdnprts esieaC"lWe e d afsrna ofI-r1. as oanra cuulaino r curdi ihrlvro The extremely rapid disappearance of Cr'-labelled red cells in a patient, Case 10, with a fulminating hemolytic process of unknown etiology was associated with an increased tissue retention of Cr'1 and with high levels of radioactivity over both spleen and liver. Autoagglutination of the red cells in the peripheral blood and hemoglobinemia were present. 20 ts subject in divided daily doses calculated to approximate the amount of hemoglobin which had been released from the Cr51-labelled red cells each day. The Cr51 injected in this manner accumulated largely in the patient's liver rather than in the spleen. Pernicious anemia. The survival time of red cells from patients with untreated pernicious anemia when transfused into normal subjects has been observed by the Ashby technique to be diminished (15, 16) . A reduced survival of red cells labe.lled with Crp5 was also observed here in a patie:it, Case 8, with moderately severe untreated pernicious anemia (Figure 10) . A moderate accumulation of Crll in the patient's non-palpable spleen was also demonstrated whereas there was no definite uptake of Cr5' by the liver.
Anemia of chronic renal disease. A patient, Case 9, with chronic "stationary" uremia had a sustained, moderately severe, normocytic, normochromic anemia. The reticulocyte levels ranged from 1 to 4 per cent; there were about 5 per cent of "burr cells" in the peripheral blood, and the bone marrow aspirate was normal in appearance and cellular composition. The patient was found to have a reduced survival time of Cr51-labelled autogenous red cells (Figure 11 ), a frequent finding in uremia (17) (18) (19) . No increased Cr5' uptake by either liver or spleen attended this process. Despite the shortened red cell survival, as in the 858 J. H. JANDL, M. S. GREENBERG, R. H. YONEMOTO, AND W. B. CASTLE patient, Case 8, with pernicious--anemia, 'it-ism-i-cels were being dee 'dailRy and that the daily teresting that by calculation underproduction was hemoglobin production averaged 55 gm. This rethe greater factor in the production of this patient's markably rapid removal of Cr51-labelled red cells anemia (Table I) .
from the blood stream was accompanied by an inAcquired hemolytic anemia. A patient, Case creased Crp5 uptake by the spleen and also, to only 10, with severe, acute, idiopathic acquired hemo-a slightly lesser extent, by the liver. A repetition lytic anemia of unknown etiology associated ini-of these studies was undertaken 3 weeks later, tially with hemoglobinemia and hemoglobinuria when auto-agglutination and hemoglobinemia had was studied on two occasions. During the first disappeared, and the signs of hemolysis had lesperiod of observation spherocytosis, mild auto-sened. At this time the patient's red cell halfagglutination of the red cells in the peripheral blood survival time had increased to 7.8 days, while the and a positive Coombs test were found, and the pa-spleen alone accumulated Cr51 ( Figure 12B) 
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The observed very abrupt clearance of Cr51CJ8 from the circulation is consistent with the propensity of cationic chromium to form colloidal molecular aggregates above a pH of 6.0. Here again, the small fraction of Cr5' not excreted was predominantly taken up by the normal liver as determined by body surface counts; the hepatic uptake of Cr5' was more striking when Cr51Cl had been incubated with serum prior to injection. These results conform with studies of the chromium distribution in rat tissues following the injection of Cr51CJ. (21) .
Because of the softness of the x-ray and gamma ray emissions of Cr51, less than 20 per cent of its radiations penetrate the trunk from a source placed beneath a normal supine subject. Nevertheless, with use of the apparatus described, the quantity of Cr5' generally employed in red cell survival studies (12) is quite adequate for body surface counting. Indeed, the low energy and penetration of these emissions reduces the factor of stray radiation from neighboring organs. An accumulation of local radiation obviously may arise from red cells in transit through or sequestered in a given organ, from released hemoglobin or from Crp5 in some other form deposited in the organ. The gradual accumulation in the urine of Crp5 presumably results in part from its slow elimination from the tissues. On the basis both of direct body counts and of the urinary excretion of Cr51, the rate of loss from the tissue was calculated in 4 subjects who had abruptly sequestered labelled sensitized red cell suspensions (9) That the sequestration of whole red cells by the spleen is indeed detectable by an attendant rise in radioactivity over the spleen was illustrated by Cases 1 and 2. In these patients with congenital hemolytic anemia the splenic Cr5' uptakes mirrored the disappearance of chromium from the blood stream (Figures 4A and 4B) . Furthermore, the injection of Cr51-Iabelled red cells from Case 2 into a normal compatible recipient also led to a high relative radioactivity over the recipient's normal-sized spleen. These observations corroborate the previously established evidence that spherocytes may be selectively retained by either pathologic or normal spleens (1) (2) (3) (4) (5) . The somewhat longer survival of autogenous Cr51-labelled spherocytes in the patient, Case 2, with mild hereditary spherocytosis than in a normal compatible recipient may have arisen from the competition for sequestration in the spleen of Case 2 by autogenous unlabelled spherocytes. The moderate hepatic and comparatively low "splenic" uptake of Cr51-labelled autogenous red cells from a patient, Case 3, with sickle cell anemia ( Figure 5A ) were interpreted as reflecting the splenic atrophy characteristic of this disease (6, 7, 22) , especially because prominent progressive increases in splenic as well as hepatic radioactivity were observed when an aliquot of the sickle cell anemia patient's labelled red cells was transfused into a compatible normal subject ( Figure SB) . That the sicklemia red cells survived only half as long in the normal subject as in the patient herself presumably indicates in part the beneficial effect on red cell survival of the "autosplenectomy" characteristic of adult patients with sickle cell anemia. This is in contrast to the short survival time, even of normal red cells, in some children with sicklemia and large spleens observed by Lichtman, Shapiro, Ginsberg, and Watson (23) . The considerable hepatic Crp5 uptake noted here also contrasts with the preponderant uptake of Crp5 by the spleen alone in congenital hemolytic anemia. These observations, again, are consistent with previous studies (1, 5-7) revealing the hematologic basis for the erythrostasis, thromboses and infarcts 861 which early cause severe damage to the spleen and which gradually injure the liver.
In addition to establishing the extent to which Cr5' is accumulated by the liver or spleen, it is possible to discriminate by means of their respective rates of increase between high relative radioactivity due on the one hand to sequestration of labelled red cells and that on the other due to simple organ enlargement with concomitant increase in vascularity. In the former situation local radioactivity necessarily builds up in an organ in approximate proportion to its rate of disappearance from the blood. In the latter situation the high initial relative activity over the organ (unless followed at once by rapid accumulation) signifies a large vascular bed rather than red cell sequestration. Thus, the presence of a high initial ratio of spleen Cr5' to precordial Cr51, i.e., greater than about 90 per cent, merely indicates splenomegaly with an attendant increase in perfusing blood and unless the ratio subsequently increases, as for example in Cases 1, 2, 4, 5, 7, 10 and 11, does not necessarily denote sequestration of red cells. A case illustrating this point is presented in Figure   FIGURE 14 This 48-year old Jewish female had splenomegaly and thrombocytopenia on the basis of Gaucher's disease. The patient was not anemic, however, and her red cell survival, as indicated above, was almost normal. Although a high relative radioactivity appeared in the enlarged spleen shortly after the injection of Cr'-labelled autogenous red cells, there was no subsequent accumulation of Cr' by the spleen.
This pattern of radioactivity reflects the vascular size of the spleen rather than the filtration of red cells. 14. This patient had splenomegaly on the basis of Gaucher's disease and showed no evidence of hemolysis. Her red cell half-survival time was about 25 days. Within a few hours of the injection of Cr51-labelled autogenous red cells the radioactivity over the spleen was 125 per cent of that over the heart; as blood Crp5 activity declined, however, there was no further uptake of radioactivity by the spleen, suggesting that this large spleen possessed a large vascular bed but did not sequester red cells. Accordingly, Crp5 may sometimes be employed to determine the nature of masses in the left upper quadrant when this is not otherwise possible. Observations (9) reported elsewhere upon the organ distribution of Cr5' and the appearance of hemoglobin in the plasma following injection of Cr51-labelled red cells after exposure to complete or to incomplete antibodies indicate the experimental association of red cell agglutination and deposition in the lung and liver with hemoglobinemia. On the other hand, the association of red cell sensitization, without manifest agglutination, was with splenic sequestration and the absence of hemoglobinemia. On the basis of the plasma hemoglobin levels these processes have classically been distinguished as "intravascular" and "extravascular" hemolysis. The former state has often been taken to indicate the presence of a circulating hemolysin despite the rarity with which hemolysins are actually demonstrable in hemolytic diseases, even in patients (such as Case 10) with fairly striking increases in plasma hemoglobin levels. These experimental observations and those clinical observations reported or referred to here indicate the general tendency of mild or of discrete red cell alterations (as encountered in spherocytes, sensitized cells, and the morphologically peculiar cells encountered in pernicious anemia and in Cooley's anemia) to lead to rather specific sequestration by the spleen presumably due to the refined filtering function of that organ. This is attended by little or no release of hemoglobin into the circulation and may be interpreted as an "extravascular" process. More severe or gross red cell changes, such as agglutination, or discrete cellular changes which may grossly affect blood viscosity, as in sickle cell anemia, lead to a more indiscriminate filtration by the capillaries, especially in the several organs with very large vascular beds: the lungs and liver, as well as the spleen if present and functioning. Such widespread red cell trapping, especially when not in close relation to concentrations of reticulo-endothelial cells, may favor the release of hemoglobin into the plasma and thus simulate the effects of a circulating hemolysin.
It is interesting to note the coexistence of red cell agglutination, a large hepatic uptake of Cr5', and high plasma hemoglobin levels at the time of the first observation on Case 10, a patient at that time with fulminating acquired hemolytic anemia. In Case 11, with an acquired hemolytic anemia of slightly less severity, the red cells were sensitized but not agglutinated, the preponderance of Cr51 activity in the spleen was striking, and there was little rise in the plasma hemoglobin level. anode of a filter paper electrophoresis cell maintained at a pH of 8.6 by barbital buffer. Under these conditions, the greater negative charge of the Cr51-labelled hemoglobin induced an increase in the electrophoretic mobility of hemoglobin of over 15 per cent. All of these observations stress the chemical alterations brought about by the Cr51-labelling procedure, and urge that care be taken to label the red cell aliquots evenly and with Na2Cr51O4 of high specific radioactivity.
Ordinarily there is no apparent necessity for washing the patient's red cells prior to re-injection or for measuring the urinary excretion of Cr.51. The chief advantage of washing the red cells prior to injection is to obviate an initial urinary hyperexcretion of Cr5l which is not derived from labelled red cells but from the plasma. The injection of a small amount of Cr51 unattached to red cells will also impair the accuracy of the initial blood volume determinations if whole blood specimen radioactivity is measured, but it should not interfere with the assessment of splenic sequestering activity.
The extensive accumulation of Cr5' observed to occur in the spleens and livers of patients with hemolytic anemias necessitates a re-appraisal of the radiation hazard involved. The radiation dosage contributed by the injection of 100 ,uC of Cr5' into a 70 Kg. subject has been estimated to be about 0.1 rep, with the assumption that the isotope is evenly distributed within the circulation and that no excretion has occurred (24) . In a patient with a hemolytic process in which the injected Cr5' is accumulated entirely by the liver and spleen, with combined organ weights of 1600 grams, the exposure to these tissues approximates 2.0 rep. If a 100 !C dose of Cr5' is accumulated entirely by a 200-gram spleen, the exposure to that organ will approximate 16.1 rep, an excessive level. Although total clearance of Cr5' by the spleen is unlikely, it is suggested that the dose of Cr51 employed in subjects with presumed hemolytic anemias be reduced to a maximum of 50 ,uC.
Cr5l in predicting the need for splenectomy After each injection of labelled red cells determination of the body surface Cr5' activity by means of three or four appropriately spaced sets of observations over precordium, liver, spleen and Table I . A tentative grading of the intensity of splenic sequestration on the basis of the index of sequestration values recorded in Table I for the 11 anemic subjects might be as follows: less than 30-subnormal; 30 to 60-normal; 60 to 100-mild to moderate; and greater than 100-moderate to severe. The employment of even such crude numerical assessments as guides in deciding the need for splenectomy will assuredly require many case studies. However, Korst, Clatanoff, and Schilling (25) have studied, with methods resembling ours, 3 patients with acquired hemolytic anemia, on whom splenectomies were later performed. In 2 of the patients high splenic accumulations of Cr51 occurred and splenectomy was beneficial; in 1 patient, in whom there was little build-up of radioactivity over the spleen, removal of the spleen was ineffectual. There are, in addition to this category of patients, other conditions sometimes characterized by splenomegaly (23, (26) (27) (28) in which, although splenectomy is usually not indicated, in individual instances removal of the spleen has benefitted the patient by decreasing the rate of red cell destruction (26) (27) (28) ). An unexpected example eventuated from the observation that radioactivity accumulated in the enlarged spleen of a patient, Case 5, with paroxysmal nocturnal hemoglobinuria following injection of Cr51-labelled red cells. Removal of the patient's 660-gram spleen produced temporarily a moderate diminution of the anemia, and thereafter the patient has required fewer transfusions to maintain a given hemoglobin concentration. It is likely that detectable instances of excessive sequestration by pathologic spleens will arise in a variety of disease states. The surprising predilection of Cr51-labelled pernicious anemia red cells for sequestration by the spleen, observed in Case 8, may explain the therapeutic value of splenectomy reported in this disease prior to the use of liver extract (29) . The fact that the defectively formed red cells characteristic of certain diseases of red cell underproduction may survive poorly, and, as in the case of pernicious anemia, despite a calculated rate of hemoglobin production that was subnormal, may be detectably sequestered by the spleen, enjoins the need to characterize the fundamental balance between red cell production and destruction in each case as clearly as possible. The anemia of chronic liver disease, for example, has been shown to be primarily hemolytic in most instances (14) . The finding that all of 4 patients with the anemia of liver disease demonstrated mild to moderate splenic uptakes of Cr51, as illustrated by Case 7, indicates the potential therapeutic value of splenectomy in such patients although only rarely is such an operation warranted. The occasional patients with congenital non-spherocytic hemolytic anemia who may benefit from splenectomy should also be identifiable by the Cr51 distribution technique.
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SUMMARY
The sites of deposition of Cr5l in the human body were determined by body surface counting following the injection into normal subjects of Cr51-labelled red cells, hemoglobin, and chromic chloride in saline. Differences characteristic of each were observed and served as a basis for interpretation of a study of a series of 11 patients with hemolytic anemias of diverse kinds. Measurements made on these patients following injection of Cr51-labelled autologous red cells suggested that progressive accumulation of Cr51 in the spleen accompanying the disappearance of Cr51-labelled red cells from the blood stream indicates active red cell sequestration. In determining the extent of this sequestration a simple expression may be employed (index of sequestration) which deducts that radioactivity initially present and due simply to the size of the splenic vascular bed from later values obtained over that organ. The methods described should in practice constitute a simple clinical device for determining the need for splenectomy. In certain hemolytic anemias the short survival of labelled red cells in the circulation is accompanied by a progressive increase of radioactivity over the spleen and the anemia is relieved by splenectomy.
